Oncogenic osteomalacia: An approach to diagnosis with a case report

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Oncogenic osteomalacia, also known as tumour induced osteomalacia, is a rare paraneoplastic syndrome caused by mesenchymal tumours secreting Fibroblast Growth Factor-23 (FGF-23). The characteristic biochemical findings include hypophosphatemia and low 1,25-dihydroxy vitamin D. The differential diagnosis for hypophosphatemia are varied. We present a case of oncogenic osteomalacia in a 29-year-old female, who presented with complaints of generalized diffuse bone pain and walking difficulty for six months duration. Thus, we have discussed the approach to diagnosis in such a case.

Cite

CITATION STYLE

APA

Dey, B., Gochhait, D., Subramanian, H., & Ponnusamy, M. (2017). Oncogenic osteomalacia: An approach to diagnosis with a case report. Journal of Clinical and Diagnostic Research, 11(4), ED05–ED07. https://doi.org/10.7860/JCDR/2017/25055.9634

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free